09955.HK
ClouDr Group Limited
HKSE · Healthcare · Medical - Distribution · CN
HKD 0.40
+0.00%Year over year
Reported trailing growth
- Revenue
- -39.7%
- EBITDA
- +103.1%
- EBIT
- +66.9%
- EPS
- +59.4%
- Free cash flow
- +118.0%
- Operating cash flow
- -36.3%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -18.4%
- EBITDA
- -36.7%
- EBIT
- —
- Net income
- -79.0%
- EPS
- -70.8%
- Free cash flow
- +71.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026